Clinical trial
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
NCT00382408 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
- Lead sponsor
- Duramed Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- December 31, 2007
- Enrollment
- 4,040 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.